FR2272646B1 - - Google Patents

Info

Publication number: FR2272646B1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

FR7513709A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nelson Research and Development Co

Original Assignee

Nelson Research and Development Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-06-03

Filing date

1975-04-30

Publication date

1978-11-10

1975-04-30 Application filed by Nelson Research and Development Co filed Critical Nelson Research and Development Co

1975-12-26 Publication of FR2272646A1 publication Critical patent/FR2272646A1/fr

1978-11-10 Application granted granted Critical

1978-11-10 Publication of FR2272646B1 publication Critical patent/FR2272646B1/fr

Status Expired legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

FR7513709A 1974-06-03 1975-04-30 Expired FR2272646B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/475,856 US3947579A (en)	1974-06-03	1974-06-03	Method and composition for potentiating neuroleptic drugs

Publications (2)

Publication Number	Publication Date
FR2272646A1 FR2272646A1 (fr)	1975-12-26
FR2272646B1 true FR2272646B1 (fr)	1978-11-10

Family

ID=23889440

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR7513709A Expired FR2272646B1 (fr)	1974-06-03	1975-04-30

Country Status (12)

Country	Link
US (1)	US3947579A (fr)
AU (1)	AU499034B2 (fr)
BE (1)	BE829830A (fr)
CA (1)	CA1048932A (fr)
DE (1)	DE2523998A1 (fr)
FR (1)	FR2272646B1 (fr)
GB (2)	GB1514311A (fr)
IE (1)	IE41374B1 (fr)
IL (1)	IL47324A (fr)
NL (1)	NL7506404A (fr)
PH (1)	PH13894A (fr)
ZA (1)	ZA753316B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2453643A2 (fr) *	1977-06-24	1980-11-07	Synthelabo	Compositions pharmaceutiques actives sur le systeme nerveux central
US4160835A (en) *	1976-11-19	1979-07-10	Merck & Co., Inc.	Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid
NL7706429A (nl) *	1977-06-10	1978-12-12	Univ Erasmus	Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
US4148896A (en) *	1978-02-22	1979-04-10	E. I. Du Pont De Nemours And Company	Antidepressant combination
US4346085A (en) *	1980-02-29	1982-08-24	Massachusetts Institute Of Technology	Process and composition for treating disorders by administering amphetamine and choline
NL8006135A (nl) *	1980-11-10	1982-06-01	Univ Erasmus	Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
US4636494A (en) *	1981-01-30	1987-01-13	Massachusetts Institute Of Technology	Process and composition for treating disorders by administering amphetamine and choline
FI832935A (fi)	1982-08-20	1984-02-21	Midit	Derivat av w-aminosyror, deras framstaellning samt dessa derivat innehaollande blandningar
US5296277A (en) *	1992-06-26	1994-03-22	Minnesota Mining And Manufacturing Company	Positionable and repositionable adhesive articles
US5637617A (en) *	1994-04-01	1997-06-10	The Regents Of The University Of California	Methods for use of GABAa receptor GABAergic compounds
US6833377B2 (en)	2001-02-05	2004-12-21	Gevys Pharmaceuticals Ltd.	Composition and method for potentiating drugs
US20050192220A1 (en) *	2001-02-05	2005-09-01	Gevys Pharmaceuticas Ltd.	Composition and method for potentiating drugs
US7544681B2 (en)	2001-09-27	2009-06-09	Ramot At Tel Aviv University Ltd.	Conjugated psychotropic drugs and uses thereof
EP2275143B1 (fr)	2001-09-27	2012-12-19	Ramot at Tel Aviv University Ltd.	Conjugués de la perphénazine ou de la fluphénazine avec des acides carboxyliques
EP2272537A3 (fr) *	2005-06-07	2014-10-22	Ramot at Tel-Aviv University Ltd.	Sels de conjuguées de médicaments psychotropiques et procédés pour leur synthèse
ES2400772T3 (es) *	2005-06-07	2013-04-12	Ramot At Tel Aviv University Ltd.	Sales novedosas de fármacos psicotrópicos conjugados y procedimientos para la preparación de las mismas
CN101511388B (zh)	2006-07-17	2012-10-24	特拉维夫大学拉莫特有限公司	含有精神药物或gaba激动剂和有机酸的缀合物以及它们在治疗疼痛和其它cns疾病中的用途
US8207369B2 (en)	2008-02-11	2012-06-26	Ramot At Tel-Aviv University Ltd.	Conjugates for treating neurodegenerative diseases and disorders
US8461389B2 (en)	2008-04-18	2013-06-11	University College Dublin, National University Of Ireland, Dublin	Psycho-pharmaceuticals
AU2010329440A1 (en)	2009-12-09	2012-08-09	Bar-Ilan University	Methods of improving cognitive functions
WO2012038963A1 (fr)	2010-09-22	2012-03-29	Ramot At Tel-Aviv University Ltd.	Sel d'addition d'acide d'un conjugué nortriptyline-gaba et son procédé de préparation
WO2016176609A1 (fr)	2015-04-30	2016-11-03	Ovid Therapeutics Inc	Procédés de traitement du syndrome de prader-willi
US9351968B1 (en)	2015-09-09	2016-05-31	Ovid Therapeutics Inc	Methods of treating developmental disorders using pipradrol
US9827233B1 (en)	2016-05-26	2017-11-28	Ovid Therapeutics Inc	Methods of treating behavioral syndromes using pipradrol
US10071083B2 (en)	2017-02-03	2018-09-11	Ovid Therapeutics Inc	Use of gaboxadol in the treatment of tinnitus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH449645A (de) *	1963-07-09	1968-01-15	Ciba Geigy	Verfahren zur Herstellung neuer Aminosäuren
US3505451A (en) *	1967-08-14	1970-04-07	Geigy Chem Corp	Compositions and methods for alleviating schizophrenia employing one of haloperidol,trifluperidol or an acid addition salt thereof and one of desipramine,imipramine and an acid addition salt thereof

1974
- 1974-06-03 US US05/475,856 patent/US3947579A/en not_active Expired - Lifetime
1975
- 1975-04-30 FR FR7513709A patent/FR2272646B1/fr not_active Expired
- 1975-05-16 GB GB20777/75A patent/GB1514311A/en not_active Expired
- 1975-05-16 GB GB1591/78A patent/GB1514312A/en not_active Expired
- 1975-05-20 IL IL47324A patent/IL47324A/xx unknown
- 1975-05-22 ZA ZA00753316A patent/ZA753316B/xx unknown
- 1975-05-22 AU AU81438/75A patent/AU499034B2/en not_active Expired
- 1975-05-28 CA CA75227970A patent/CA1048932A/fr not_active Expired
- 1975-05-30 DE DE19752523998 patent/DE2523998A1/de not_active Ceased
- 1975-05-30 NL NL7506404A patent/NL7506404A/xx not_active Application Discontinuation
- 1975-06-03 PH PH17222A patent/PH13894A/en unknown
- 1975-06-03 BE BE156998A patent/BE829830A/fr not_active IP Right Cessation
- 1975-06-03 IE IE1237/75A patent/IE41374B1/xx unknown

Also Published As

Publication number	Publication date
IE41374B1 (en)	1979-12-19
DE2523998A1 (de)	1975-12-11
IL47324A0 (en)	1975-08-31
AU8143875A (en)	1976-11-25
AU499034B2 (en)	1979-04-05
PH13894A (en)	1980-10-27
NL7506404A (nl)	1975-12-05
IL47324A (en)	1979-03-12
GB1514311A (en)	1978-06-14
US3947579A (en)	1976-03-30
FR2272646A1 (fr)	1975-12-26
ZA753316B (en)	1976-04-28
CA1048932A (fr)	1979-02-20
GB1514312A (en)	1978-06-14
IE41374L (en)	1975-12-03
BE829830A (fr)	1975-10-01

Legal Events

Date	Code	Title	Description
1985-02-22	ST	Notification of lapse

Publication	Publication Date	Title
IN142257B (fr)	1977-06-18
FR2272646B1 (fr)	1978-11-10
FR2318925B1 (fr)	1979-05-18
FR2279565B1 (fr)	1977-01-07
FR2280571B1 (fr)	1978-02-17
JPS50118252A (fr)	1975-09-16
JPS50101958U (fr)	1975-08-22
AR198466A1 (fr)	1974-06-21
FR2256999B1 (fr)	1979-04-06
FR2259139A1 (fr)	1975-08-22
JPS50123206A (fr)	1975-09-27
AR197698Q (fr)	1974-04-30
JPS50101310A (fr)	1975-08-11
JPS50111116U (fr)	1975-09-10
JPS50112770U (fr)	1975-09-13
BG20145A1 (fr)	1975-11-05
CH573583A5 (fr)	1976-03-15
BG20839A1 (fr)	1976-01-20
BG20658A1 (fr)	1975-12-20
BG21094A1 (fr)	1976-03-20
BG21169A1 (fr)	1976-03-20
BG21502A1 (fr)	1976-07-20
BG21057A1 (fr)	1976-03-20
BG21660A1 (fr)	1976-09-20
BG20053A1 (fr)	1975-10-30